Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

Autor: Jørgensen, S. F.1,2,3 (AUTHOR) s.f.jorgensen@medisin.uio.no, Macpherson, M. E.1,2,3 (AUTHOR), Bjørnetrø, T.1,4 (AUTHOR), Holm, K.1,3,4 (AUTHOR), Kummen, M.1,4 (AUTHOR), Rashidi, A.1 (AUTHOR), Michelsen, A. E.1,3 (AUTHOR), Lekva, T.1 (AUTHOR), Halvorsen, B.1,3 (AUTHOR), Trøseid, M.1,2,3 (AUTHOR), Mollnes, T. E.5,6,7 (AUTHOR), Berge, R. K.8,9 (AUTHOR), Yndestad, A.1,3 (AUTHOR), Ueland, T.1,3 (AUTHOR), Karlsen, T. H.1,3,4 (AUTHOR), Aukrust, P.1,2,3 (AUTHOR), Hov, J. R.1,3,4 (AUTHOR), Fevang, B.1,2 (AUTHOR)
Zdroj: Scientific Reports. 2/15/2024, Vol. 14 Issue 1, p1-1. 1p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje